Meta description: Spravato prior authorizations get denied for preventable front-end reasons. Here is how to get them approved the first time and keep them from lapsing.
Spravato (esketamine) can be life-changing for patients with treatment-resistant depression, but it is also one of the authorization-heavy treatments a behavioral health practice will handle. Nearly every payer requires a prior authorization before the first dose, and a single missing piece can delay treatment or leave a session unpaid.
I am Belinda Joseph, a Fractional Patient Access Director with 20 years in behavioral health. I do not do billing. I work on the front end, where Spravato authorizations are won or lost, before the patient ever sits down. Here is how to get them approved the first time.
Why do Spravato prior authorizations get denied?
Most Spravato denials are not about the medication itself. They are about front-end details that were missing or incomplete when the authorization was submitted. The most common causes are missing documentation of treatment-resistant depression, no record of prior antidepressant trials, benefits that were never fully verified, or an authorization that lapsed mid-treatment. Every one of these is preventable.
What do payers usually require for Spravato?
Requirements vary by payer, plan, and state, so this is not a universal checklist. But most plans look for some combination of the following:
- A documented diagnosis of treatment-resistant depression, or the specific indication the plan covers
- Evidence that the patient has tried and failed an adequate number of other antidepressants, often two or more, at adequate dose and duration. This is called step therapy.
- Confirmation the medication will be given in a certified setting under the required monitoring
- The prescribing provider's information and, in many cases, active credentialing with that payer
Because Spravato is a REMS-program medication, payers also want to see that it will be administered and monitored the right way. Getting this documentation together before you submit is the single biggest thing that speeds approval.
How do you complete the prior authorization, step by step?
-
Verify the patient's real behavioral health benefits first, including whether Spravato is covered, whether it runs through a behavioral carve-out, and what the plan requires. Do this before scheduling anything. The SPRAVATO withMe support resources explain how benefit investigations may include medical and pharmacy benefit coverage, behavioral health organizations, and REMS-certified pharmacies.
-
Gather the clinical documentation, the diagnosis, prior medication trials with dates and outcomes, and the treatment plan. Incomplete trial history is a top denial reason.
-
Confirm the provider is credentialed and active with that payer. An authorization tied to a provider who is not in-network can be denied on that basis alone.
-
Submit the prior authorization through the payer's required channel, with every field complete and the documentation attached.
-
Track the approval details closely, especially the start date, the end date, and the number of sessions or units approved.
-
Set a reminder to reauthorize before it expires. Spravato is given over a series of sessions, and a lapse partway through can turn covered care into unpaid sessions.
How do you keep Spravato authorizations from lapsing?
The lapse is the hidden revenue leak. An authorization gets approved, treatment starts, and weeks later the approved sessions run out while the patient is still in active treatment. The fix is simple but has to be consistent: track every authorization's end date and remaining sessions in one place, and start the reauthorization well before the last approved session, not after.
A payer's requirements can also change by indication and plan. For example, current UnitedHealthcare criteria identify documentation such as a DSM-based diagnosis, baseline depression assessment, prior treatment history, and REMS certification. Current Cigna criteria also distinguish between treatment-resistant depression and major depressive disorder with acute suicidal ideation or behavior. Review the specific plan policy rather than relying on a previous authorization or a general checklist.
Frequently asked questions
Is a Spravato prior authorization the same as billing?
No. The prior authorization is front-end work that happens before treatment: verification, documentation, and submission. Billing comes later. Getting the authorization right is what makes the billing actually get paid.
How long does a Spravato prior authorization take?
It varies by payer, but a complete, well-documented submission moves far faster than one that comes back with requests for more information. Most delays come from missing documentation, not slow payers.
What happens if the authorization lapses mid-treatment?
Sessions given after the authorization ends are usually not covered, which means unpaid care for the practice. This is why tracking end dates and reauthorizing early matters so much.
The bottom line
Spravato prior authorizations are not hard, but they are unforgiving. Verify the real benefits, document the diagnosis and prior trials, confirm credentialing, submit a complete request, and track the end dates so nothing lapses. Do that consistently and your approvals go through the first time.
If your practice offers Spravato or TMS and you are not sure whether your authorization process is airtight, I would be glad to take a look. I offer a free Revenue Leak Audit: I review your verification, prior authorization, and credentialing, then send you a short report on what may be slipping and what I would fix first. No cost, no billing, no obligation. You can request one at almonordaisolutions.com.
Reference note: Payer requirements vary by plan, benefit type, indication, and state. Always confirm current requirements with the patient's plan, review the official Spravato prescribing information, and verify REMS requirements through SPRAVATO REMS.